logo

For the Inventor, By the Inventor

David John Morgans, Jr

Los Altos, CA, United States of America

David John Morgans, Jr

LinkedIn
USPTO Granted Patents = 100 

Average Co-Inventor Count = 6.4

ph-index = 22

Forward Citations = 1,127(Granted Patents)

Forward Citations (Not Self Cited) = 913(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Palo Alto, CA (US) (1993 - 1996)
  • Sunnyvale, CA (US) (1995 - 1999)
  • Los Altos, CA (US) (1997 - 2024)
  • South San Francisco, CA (US) (2007 - 2024)

Company Filing History:

goldMedal72 out of 257 
 
Cytokinetics, Inc.
 patents
silverMedal14 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal12 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
4. 9 out of 15 
 
Pliant Therapeutics, Inc.
 patents
5. 3 out of 3 
 
Maze Therapeutics, Inc.
 patents
6. 2 out of 12 
 
Iconix Pharmaceuticals, Inc.
 patents
7. 1 out of 1,971 
 
Amgen Inc.
 patents
8. 1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...
Areas of Expertise:
Amino Acid Compounds
APOL1 Inhibitors
Integrin Inhibitors
Glycogen Synthase Inhibitors
N-acyl Amino Acids
Imidazo[4,5-b]pyrazines
Heterocyclic Sulfonamides
Ureas
Anti-Cancer Agents
Mitotic Kinesin Inhibitors
Chemical Entities
Compositions and Methods
100 patents (USPTO):Explore Patents
1. RE50554 - Amino acid compounds and methods of use (2025-08-26),
2. 12344610 - APOL1 inhibitors and methods of use (2025-07-01),
3. 12264133 - Compounds, compositions and methods (2025-04-01),
4. 11976067 - APOL1 inhibitors and methods of use (2024-05-07),
5. 11952376 - Substituted amino acids as integrin inhibitors (2024-04-09),
6. 11814367 - Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof (2023-11-14),
7. 11673887 - N-acyl amino acid compounds and methods of use (2023-06-13),
8. 11634418 - Amino acid compounds and methods of use (2023-04-25),
9. 11560376 - Amino acid compounds and methods of use (2023-01-24),
10. 11180494 - Substituted amino acids as integrin inhibitors (2021-11-23),
11. 10975034 - Compounds, compositions and methods (2021-04-13),
12. 10793564 - Amino acid compounds and methods of use (2020-10-06),
13. 10766899 - Methods for preparing substituted imidazo[4,5-b]pyrazines (2020-09-08),
14. 10696672 - Amino acid compounds and methods of use (2020-06-30),
15. 10604520 - N-acyl amino acid compounds and methods of use (2020-03-31),

Title: The Innovative Mind of David John Morgans, Jr.

Introduction: David John Morgans, Jr. is a distinguished inventor based in Los Altos, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: David John Morgans, Jr. holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, David John Morgans, Jr. has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have positively impacted industries worldwide.

Collaborations: Throughout his career, David John Morgans, Jr. has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of creativity and excellence in the innovation landscape.

Conclusion: David John Morgans, Jr.'s passion for innovation, coupled with his relentless drive to create a better future through his inventions, solidifies his position as a visionary inventor shaping the world of tomorrow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…